According to Transparency Market Research’s latest report on the global chemiluminescence immunoassay analyzers market for the historical period 2017 - 2018 and forecast period 2019-2027, high incidence & prevalence of chronic diseases to escalate the growth of global chemiluminescence immunoassay (CLIA) analyzers market.
- Wilmington, Delaware, United States, Transparency Market Research Inc.: According to Transparency Market Research’s latest report on the global chemiluminescence immunoassay analyzers market for the historical period 2017 - 2018 and forecast period 2019-2027, high incidence & prevalence of chronic diseases to escalate the growth of global chemiluminescence immunoassay (CLIA) analyzers market. Moreover, increase in demand for laboratory automation is boost the growth of market
- According to the report, the global chemiluminescence immunoassay (CLIA) analyzers market was valued at US$ 5.04 Bn in 2018 and is anticipated to expand at a CAGR of 6.3% from 2019 to 2027
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31517
Growing Demand for International Accreditations and Result Comparability Using High Throughput Automated Immunoassays and Increase in Prevalence of Chronic Diseases: Key Drivers of Global Chemiluminescence Immunoassay (CLIA) Analyzers Market
- Sedentary lifestyle and unhealthy diet is leading to surge in prevalence & incidence of chronic diseases. For instance, according to World Health Organization (WHO), in 2018 cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths globally.
- Chronic disease prevalence has increased over time due to an aging population. Moreover, smoking, and body mass index, which are widely known risk factors for chronic diseases such as cancer, cardiovascular disease, etc. thus rise in prevalence of various chronic diseases propel the growth of market
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=31517
- Moreover, major focus of physicians and pathologists operating in in-patient or out-patient settings of the chemiluminescence immunoassay (CLIA) analyzers market is to improve the rate of standardization of the assays. The main objective behind calibration of the assays is to compare the results of the test to the well-established standards while handing out the test results to patients.
- The CLIA instruments are closed system multiplexed automated analyzers along with high throughput. These systems are relatively easy to calibrate. The CLIA analyzers are manufactured as per guidelines set by regulatory authorities. The CLIA test manufacturers also offer internal reference standard material to make their results more comparable when compared with other manual assay systems.
- Thus, growing demand for international accreditations and result comparability using high throughput automated immunoassays is likely to drive the global chemiluminescence immunoassay (CLIA) analyzers market
- To address these demands, the industry players are investing in the research and development activities to develop and introduce new products thereby boosting the global chemiluminescence immunoassay (CLIA) analyzers market
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31517
Technological Advancements Propel Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Growth
- A major technological trend observed in the global chemiluminescence immunoassay analyzers market is the introduction of next-generation integrated immunoassays. For instance, in October 31, 2017, Abbott announced the FDA 510(k) clearance for Alinity ci-series, instruments for clinical chemistry and immunoassay diagnostics. This innovation in multiplexed assays is likely to drive the global CLIA analyzers market during the forecast period
- Moreover, major manufacturers operating in the global CLIA analyzers market are involved in the expansion of their test portfolio through continuous research and development activities. For instance, in December 26, 2017, Danaher (Beckman Coulter, Inc.) received FDA clearance for its Access AMH immunoassay, the first immunoassay that uses recombinant human antigens for determination of anti-Müllerian hormone (AMH) levels. The increasing preference for continuous research with an objective of expansion of test portfolio by major as well as emerging players is likely to result in growth of the global CLIA analyzers market during the forecast period
Get COVID-19 Analysis on Chemiluminescence Immunoassay (CLIA) Analyzers Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=31517
Fragmented Consumables Market Affecting Profit Margin to Hamper Global Chemiluminescence Immunoassay (CLIA) Analyzers Market
- Continuous expansion of test offering portfolio has resulted in increasing number of emerging market players offering test kits for specific test application at affordable prices
- Product offering at relatively lower average selling price has resulted in increasing market penetration of local players having wide distribution network in certain geographies
- This is imposing pricing pressure on major manufacturers, thereby intensifying competition. Additionally, there are other technology alternatives that are available in the market at relatively lower cost per procedure, which is also affecting the geographic expansion of major players.
More Trending Reports by Transparency Market Research:
Molecular Cytogenetics Market- https://www.transparencymarketresearch.com/molecular-diagnostics-market.html
Biochip Products and Services Market- https://www.transparencymarketresearch.com/biochip-products-services.html
Cell Surface Markers Market- https://www.transparencymarketresearch.com/cell-surface-markers-market.html
Transcriptomics Technologies Market- https://www.transparencymarketresearch.com/transcriptomics-technologies-market.html
SNP Genotyping and Analysis Market- https://www.transparencymarketresearch.com/snp-single-nucleotide-polymorphism-market.html
Prenatal and New-born Genetic Testing Market- https://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html
Ophthalmology Diagnostics & Surgical Devices Market- https://www.transparencymarketresearch.com/ophthalmology-diagnostics-surgical-devices.html
Immunoprotein Diagnostic Testing Market- https://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com